Status:
COMPLETED
The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients.
Lead Sponsor:
Uute Scientific Oy
Collaborating Sponsors:
Tampere University
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of the study is to explore the effect of nature-based exposure on immunological biomarkers and the condition and symptoms of atopic skin. Our hypothesis is that regular exposure to nature-...
Eligibility Criteria
Inclusion
- A person aged 18-65, legally competent
- Meets Hanifin \& Rajka's criteria for atopic dermatitis in the initial interview and eczema has also appeared regularly in adulthood
- The possibility to commit to the research
Exclusion
- Cancer or cancer treatments
- Medication that suppresses the immune system (excluding antihistamines)
- Systemic medicine intended for the treatment of atopic dermatitis (orally or as an injection, other than an antihistamine) or the use of clinical phototherapy in the last 6 months.
- Skin infection (such as a eczema that required antibiotic cream or a parasitic infection, e.g.scabies mite) during the last 6 months
- Atopic dermatitis that required hospitalization in the last 2 years
- Psoriasis or other skin disease affecting the study in addition to atopy
- Pregnancy or breastfeeding
Key Trial Info
Start Date :
August 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT06129136
Start Date
August 17 2023
End Date
December 31 2024
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uute Scientific Oy
Helsinki, Finland, 00290